Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$9.11 - $13.98 $21,864 - $33,552
-2,400 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.87 - $11.11 $16,488 - $26,664
2,400 New
2,400 $22,000
Q3 2021

Nov 15, 2021

SELL
$26.46 - $37.15 $140,238 - $196,895
-5,300 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$32.73 - $47.95 $81,824 - $119,875
2,500 Added 89.29%
5,300 $194,000
Q1 2021

May 17, 2021

SELL
$40.39 - $56.73 $335,237 - $470,859
-8,300 Reduced 74.77%
2,800 $126,000
Q4 2020

Feb 16, 2021

BUY
$51.77 - $66.18 $243,319 - $311,046
4,700 Added 73.44%
11,100 $633,000
Q2 2020

Aug 14, 2020

BUY
$37.05 - $65.03 $237,119 - $416,192
6,400 New
6,400 $382,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.